Showing 1191-1200 of 9921 results for "".
Practical Considerations for Treating Psoriasis: Focus on Secukinumab
https://practicaldermatology.com/topics/psoriasis/practical-considerations-for-treating-psoriasis-focus-on-secukinumab/20841/Topical Steroid Withdrawal in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-steroid-withdrawal-in-atopic-dermatitis/23079/Exploring the important role and proper use of topical corticosteroids in the management of eczema.Assessment of Superficially-placed Microaliquots of Small-particle HA
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/assessment-of-superficially-placed-microaliquots-of-small-particle-ha/23611/A prospective, open-label clinical trial assesses micro-injections of transparent hyaluronic acid gel for cheek rejuvenation.Diversity and Inclusion in Dermatology: The Impact of Systemic Racism in Dermatology and Opportunities for Change
https://practicaldermatology.com/issues/supplements/diversity-and-inclusion-in-dermatology-the-impact-of-systemic-racism-in-dermatology-and-opportunities-for-change/23474/Providing the Best Outcomes with Dermal Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/glaser/18972/What can we look forward to in the way of fillers in the year ahead? According to Dee Anna Glaser, MD, there may be several new tools in your tool chest, but in the end, it's how they're utilized that's most important. Dr. Glaser, Vice Chairman, Dept. of Dermatology, St. Louis University School ofDermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.DermwireTV — Revance’s Neurotoxin Promising, Celebs Fight Melanoma with L’Oreal
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-revance-rsquo-s-neurotoxin-promising-celebs-fight-melanoma-with-l-rsquo-oreal/19138/In this weeks DermwireTV, patient safety is explored, L'Oreal supports melanoma research and Revance reports positive data for novel neurotoxin.New in My Practice: OTC Skincare/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-skincarenew-products/23704/Physician Spotlight: Murad Alam, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-murad-alam-md/23172/New in My Practice Rx: Seysara (sarecycline)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx-seysara-sarecycline/20810/